Trial Profile

A Phase 2, Multi-Centre, Randomised, Double-Blind, Sham Controlled Proof of Concept Trial Evaluating the Efficacy and Safety of TenoMiR by Injection in Subjects With Lateral Epicondylitis

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 30 Mar 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

19 Mar 2026 According to the Causeway Therapeutics media release, data from the trial were presented at RNA Leaders Europe 2026 taking place in Vienna, Austria on March 17-19, 2026.
19 Mar 2026 Results presented in the Causeway Therapeutics Media Release
28 Oct 2025 According to the Causeway Therapeutics media release, Based on these data, company is planning a Phase 3 study of TenoMiR for lateral epicondylitis and a Phase 2 study of TenoMiR in patients with rotator cuff tendinopathy.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com